By vgreene, 27 September, 2017 Achieving abstinence There s insufficient no evidence I N that cannabinoids are effective in achieving abstinence from addictive substances 1
By vgreene, 27 September, 2017 TBI/Intracranial hemorrhage. Limited evidence [L] exists for cannabinoids and a statistical assoc w/ better outcomes (ie, mortality, disability), per NAS1
By vgreene, 27 September, 2017 ALS sx. There's insufficient/no evidence [I/N] that cannabinoids are effective, per NAS1
By vgreene, 27 September, 2017 Huntington. There's insufficient/no evidence [I/N] that oral cannabinoids are effective for chorea and certain neuropsych sx, per NAS.1 AAN2 concluded that studies were underpowered, so no reliable conclusions could be drawn
By vgreene, 27 September, 2017 Parkinson. There's insufficient/no evidence [I/N] that cannabinoids are effective for Parkinson motor sx or levodopa-induced dyskinesia, per NAS.1 AAN2 concluded that oral cannabis extract is probably ineffective for levodopa-induced dyskinesis
By vgreene, 27 September, 2017 Spasticity in spinal cord-injury paralysis. There's insufficient/no evidence [I/N] that cannabinoids are effective, per NAS1
By vgreene, 27 September, 2017 Dystonia. There's insufficient/no evidence [I/N] that nabilone and dronabinol are effective, per NAS.1 AAN2 concluded that data on dronabinol for cervical dystonia are insufficient
By vgreene, 27 September, 2017 Tourette. There's limited evidence [L] that THC capsules are effective for improving sx, per NAS.1 AAN2 concluded that data on THC for ↓ tic severity are insufficient
By vgreene, 27 September, 2017 Dementia. There's limited evidence [L] that cannabinoids are ineffective for improving sx assoc w/ dementia, per NAS1
